| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4228457 | European Journal of Radiology | 2006 | 12 Pages |
Abstract
Continuous development of new contrast agents remains worthwhile to get the best adequacy between the physiological phenomenon of interest and the pharmacokinetic of the agent.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Nicolas Grenier, Michael Pedersen, Olivier Hauger,